Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
Mohamed F Doheim, Assistant Professor in Neurology (Clinical Research), NIH StrokeNet Fellow at the University of Pittsburgh School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neurology, adding:
”Excited to share my second publication in Neurology in a single day; this time on extended-window IV thrombolysis (IVT) for acute ischemic stroke (4.5–24 hours).
Across 18 RCTs and 5,168 patients, extended-window IVT improved excellent and good functional outcomes and reduced disability on the full mRS spectrum, with the expected increase in sICH but no excess mortality.
The central insight is why trial results have looked so heterogeneous.
Using multivariable meta-regression, we found that the main driver of between-study heterogeneity is whether patients also have access to endovascular thrombectomy (EVT).
Once EVT context is accounted for, much of the apparent variability in IVT effect becomes explainable.
Clinically, this means extended-window IVT may offer its greatest benefit in settings where thrombectomy is unavailable or delayed, especially for more severe strokes, positioning late IVT as a critical global reperfusion strategy rather than a niche protocol.
Proud to help clarify how IVT and EVT interact across trials and health systems, and to contribute evidence that can inform both guideline discussions and stroke systems of care worldwide.”
Title: Exploring Between-Study Heterogeneity in Extended-Window IV Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of 18 Randomized Controlled Trials
Authors: Mohamed F. Doheim, Abdullah M. Al-Qudah, Romil Singh, Nirav R. Bhatt, Marcelo Rocha, Lawrence R. Wechsler, Gaoting Ma, Gisele Sampaio Silva, Sheila Co Martins, Chunrong Tao, Junwei Hao, Yamei Tang, Wei Hu, Lee H. Schwamm, Thanh N. Nguyen, Raul G. Nogueira

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience